What did @tiana.prime actually say?
The creator described being stopped by Australian Border Force while travelling with peptides. She said she left her peptides in Bali on the return trip to avoid risk, was told that "anything with growth hormones" carries the biggest fines, that "no peptides are TGA approved," and that consequences depend on the specific peptide and quantity. Her bottom line: "it's just not worth it" unless you have a prescription.
This is a personal anecdote, not a regulatory guide. She's sharing lived experience at the border, which has real informational value, but she also mixes accurate observations with some notable inaccuracies that could mislead people into either underestimating or misunderstanding the actual legal framework.
Does the science back this up?
The regulatory picture is more specific than the video lets on. The Therapeutic Goods Administration (TGA) does have approved peptide-based medicines on the Australian Register of Therapeutic Goods (ARTG). The claim that "no peptides are TGA approved" is simply incorrect.
Semaglutide (Ozempic), liraglutide (Victoza), and insulin analogues are all peptide-based drugs with full TGA approval. Growth hormone itself, synthetic somatropin, is Schedule 4 in Australia, meaning it requires a prescription but is legally importable under a valid script. The creator seems to conflate "the peptides I use" with "all peptides," which is a significant error. The Personal Importation Scheme allows Australians to import up to three months' supply of certain medicines for personal use, but only if the product is not otherwise prohibited and is for a legitimate therapeutic purpose. Peptides marketed as research chemicals or without a prescription from a registered practitioner occupy a genuinely grey, and often illegal, zone under the Therapeutic Goods Act 1989.
What did they get wrong (or right)?
She got some things right. The risk differential between leaving and entering Australia is real. Border Force applies more scrutiny to incoming goods and travellers, and having a prior flag on your record does create additional risk at future border interactions. That's consistent with how border risk profiling generally works.
She also got it right that quantity and specific substance matter. Australian customs distinguishes between substances scheduled under the Poisons Standard, and enforcement is not uniform across all peptides.
Where she was wrong: describing growth hormone-related peptides as simply "the biggest fines" understates the situation considerably. Importation of anabolic steroids or unapproved growth hormone products without a prescription can constitute a criminal offence under the Customs Act 1901 and the Therapeutic Goods Act 1989, not just a civil fine. And the blanket claim that "no peptides are TGA approved" is factually incorrect, as multiple peptide-based medicines hold full TGA approval.
What should you actually know?
If you are using peptides prescribed by a registered Australian practitioner through a TGA-authorised compounding pharmacy, your legal standing is very different from someone carrying unlabelled vials purchased online. These are not equivalent situations, and the video does not make that distinction clearly enough.
The Personal Importation Scheme exists but carries strict conditions. The TGA's own guidance states that products must be for personal use, in quantities no greater than three months' supply, and the product cannot be a prohibited import or a controlled drug. Many peptides commonly discussed in wellness communities, including BPC-157, TB-500, and CJC-1295, are not on the ARTG and have no approved therapeutic indication in Australia. That makes their import status genuinely risky regardless of how benign the creator found the interaction.
The creator's core advice, "just not worth it" without a script, is actually sound. But the reasoning she gives to get there has enough errors that following her logic rather than her conclusion could get someone in real trouble.
- BPC-157 has no TGA approval and limited human trial data. Most evidence is rodent-based (Sikiric et al., 2018, Current Pharmaceutical Design).
- TB-500 (Thymosin Beta-4) has Phase II trial data in cardiac repair (Goldstein et al., 2012, Annals of the New York Academy of Sciences) but no approved human therapeutic indication in Australia.
- Growth hormone secretagogues like ipamorelin and CJC-1295 are not approved for general use and are specifically listed as prohibited substances in sport by WADA.